Explore popular drugs in clinical trials

Check which drugs are currently being frequently studied.

See also our rare diseases glossary and popular diseases list.

Starting by letter

To open the drugs glossary, select a letter from the list below.

Most popular drugs

The list below features the most popular substances currently involved in ongoing clinical trials.

Drug Trials
Pembrolizumab 462
Sodium Chloride 431
Carboplatin 345
Cisplatin 287
Paclitaxel 263
Fluorouracil 238
Oxaliplatin 229
Nivolumab 217
Dexamethasone 211
Rituximab 200
Cyclophosphamide 191
Durvalumab 169
Bevacizumab 168
Capecitabine 160
Paracetamol 160
Atezolizumab 147
Docetaxel 133
Prednisone 129
Tocilizumab 126
Prednisolone 125
Mycophenolate Mofetil 122
Gemcitabine 122
Doxorubicin Hydrochloride 118
Venetoclax 118
Pemetrexed 117
Etoposide 116
Lenalidomide 102
Infliximab 102
Semaglutide 96
Acetylsalicylic Acid 94
Ipilimumab 92
Folinic Acid 90
Placebo 89
Paclitaxel Albumin-Bound 85
Calcium Folinate 83
Daratumumab 83
Fludarabine Phosphate 80
Cytarabine 79
Methotrexate 79
Letrozole 77
Dapagliflozin 76
Bortezomib 75
Gemcitabine Hydrochloride 73
Olaparib 72
Obinutuzumab 68
Tacrolimus 67
Lenvatinib 67
Azacitidine 67
Trastuzumab 66
Cetuximab 65
Fulvestrant 64
Irinotecan 63
Irinotecan Hydrochloride Trihydrate 62
Temozolomide 59
Methylprednisolone 59
Cemiplimab 57
Vincristine Sulfate 57
Trastuzumab Deruxtecan 53
Apixaban 53
Lidocaine Hydrochloride Monohydrate 52
Enzalutamide 52
Amoxicillin 51
Betamethasone Sodium Phosphate 50
Ribociclib 49
Dexamethasone Sodium Phosphate 49
Codeine Phosphate 49
Hydrocortisone 48
Exemestane 48
Lidocaine Hydrochloride 48
Buclizine Hydrochloride 47
Empagliflozin 47
Anastrozole 47
Adalimumab 47
Potassium Chloride 46
Clavulanic Acid 45
Pomalidomide 44
Tenofovir Alafenamide 44
Pertuzumab 44
Oxygen 44
Abemaciclib 43
Ibrutinib 43
Clopidogrel 43
Doxorubicin 43
Rivaroxaban 42
Ruxolitinib 42
Propofol 42
Trimethoprim 41
Sulfamethoxazole 41
Atorvastatin 41
Cabozantinib 41
Cyclophosphamide Monohydrate 41
Emtricitabine 40
Ropivacaine Hydrochloride 40
Palbociclib 40
Metformin Hydrochloride 40
Carfilzomib 40
Linezolid 39
Bendamustine Hydrochloride 39
Dostarlimab 38
Acalabrutinib 38

New drugs in trials

The list below features the new substances involved to ongoing clinical trials.

#1 VMX-C001

Clinical trials are studying VMX-C001 in people who take a Factor Xa direct oral anticoagulant and need urgent surgery or another high-bleeding-risk procedure.

3 months ago
#2 LIPASE

Clinical trials are investigating LIPASE, including a new lipase product compared with pancrelipase.

3 months ago
#3 TRIACYLGLYCEROL LIPASE

Clinical trials of TRIACYLGLYCEROL LIPASE are studying a new lipase treatment in adults with exocrine pancreatic insufficiency.

3 months ago
#4 IMA401

Clinical trials are investigating IMA401 in patients with recurrent and/or refractory solid tumors.

3 months ago
#5 ALLERGEN EXTRACTS

Clinical trials are studying BLOMIA TROPICALIS POLYMERIZED EXTRACT as part of a vaccine for dust mite and Blomia tropicalis allergy.

3 months ago
#6 AUR200

Clinical trials are investigating AUR200 in people with generalized myasthenia gravis.

3 months ago

Drugs starting by q

  • 10 

    Quavonlimab

    ,

    Quavonlimab is an investigational drug being studied in clinical trials for the treatment of advanced solid tumors, including non-small cell lung cancer (NSCLC). These trials are exploring how Quavonlimab works in combination with other cancer drugs, particularly pembrolizumab, to potentially improve outcomes for patients with advanced cancers. The studies are evaluating the safety, effectiveness, and optimal dosing of these drug combinations in different patient groups.

  • 1 

    Quc398

    ,

    A groundbreaking clinical trial is underway to investigate the potential benefits of QUC398, a new drug designed to address knee osteoarthritis. This study aims to evaluate the drug’s effectiveness in reducing pain, preserving cartilage, and improving overall knee function in patients suffering from this common joint condition. The trial’s results could pave the way for a novel treatment option for those struggling with knee osteoarthritis.

  • 4 

    Quemliclustat

    ,

    This article explores the use of Quemliclustat, an innovative drug, in various clinical trials for cancer treatment. Quemliclustat, also known as AB680, is being studied in combination with other drugs and therapies to potentially enhance the body’s immune response against different types of cancer. These trials aim to evaluate the safety, efficacy, and potential benefits of Quemliclustat in treating advanced cancers, including pancreatic, prostate, and gastrointestinal malignancies.

  • 2 

    Quercetin

    , , ,

    Quercetin, a naturally occurring flavonoid found in various plants and fruits, has been the subject of numerous clinical trials investigating its potential therapeutic effects. These studies have explored quercetin’s role in treating a wide range of conditions, including gastroesophageal reflux disease (GERD), chronic obstructive pulmonary disease (COPD), coronary artery disease, post-operative pain, and even COVID-19. This article summarizes the key findings from recent clinical trials, highlighting the promising applications of quercetin in medical research.

  • 1 

    Quercus Ilex Allergen Extract

    ,

    This article discusses a clinical trial investigating the use of Quercus Ilex (Holm Oak) allergen extract in diagnosing oak pollen allergy. The study aims to determine the optimal concentration of the extract that produces a skin reaction equivalent to a standard histamine solution, potentially improving the accuracy of allergy testing for patients with oak pollen sensitivities.

  • 1 

    Quercus Robur Pollen Extract

    ,

    This article discusses a clinical trial investigating the use of Quercus Robur (Oak) Pollen Extract in diagnosing oak pollen allergies. The study aims to determine the effectiveness of this extract in skin prick tests, which are commonly used to identify allergies. This research is important for improving the accuracy of oak pollen allergy diagnoses and potentially enhancing treatment options for those affected.

  • 6 

    Quetiapine

    ,

    Quetiapine, also known by its brand name Seroquel, is an antipsychotic medication that has been studied in various clinical trials for its potential benefits in treating different mental health conditions. These trials have explored its use in schizophrenia, bipolar disorder, major depressive disorder, and other psychiatric conditions. The studies have examined different formulations, dosages, and patient populations to better understand quetiapine’s effectiveness, safety profile, and optimal use in clinical practice.

  • 2 

    Quinapril Hydrochloride

    , ,

    This article explores the use of Quinapril Hydrochloride in clinical trials for treating hypertension (high blood pressure) and improving cardiovascular health. Quinapril Hydrochloride is a medication that belongs to a class of drugs called ACE inhibitors, which help relax blood vessels and lower blood pressure. We’ll examine various studies that have investigated the efficacy, safety, and potential benefits of Quinapril Hydrochloride, both alone and in combination with other medications, for patients with mild to moderate hypertension and related conditions.

  • 2 

    Quinidine Sulfate

    ,

    Quinidine sulfate, a medication primarily known for its antiarrhythmic properties, has been the subject of several clinical trials exploring its potential uses in various medical conditions. These trials aim to investigate the drug’s efficacy, safety, and interactions with other medications. The studies cover a range of applications, from treating heart rhythm disorders to potential benefits in neurological conditions and drug interactions.

  • 1 

    Quinine Dihydrochloride

    This article discusses the use of Quinine Dihydrochloride in clinical trials for Parkinson’s Disease (PD). While the primary focus of the trial is on another drug called Fasudil, Quinine Dihydrochloride is mentioned as a comparator or reference drug. The study aims to evaluate the safety, tolerability, and potential efficacy of these medications in managing PD symptoms.

  • 5 

    Quizartinib Dihydrochloride

    , ,

    Quizartinib Dihydrochloride, also known as Quizartinib, is a drug currently being studied in clinical trials for the treatment of acute myeloid leukemia (AML), particularly in patients with FLT3-ITD mutations. This article explores the ongoing research and potential benefits of Quizartinib in treating this aggressive form of blood cancer.